
Britain First Approves Oral Covid-19 Drug For Critical Patients
On Thursday, Britain became the first country in the world to approve an antiviral pill jointly developed by Merck Inc & Ridgeback Biotherapeutics to use in Covid-19 treatment. Oral medicine is expected to play a game-changing role as a booster instrument to fight against the COVID-19 pandemic. MHRA, Britain’s Medicines, and Healthcare products Regulatory Agency